OPEN END TURBO LONG - APTARGROUP Share Price

Certificat

DE000MB100F1

Market Closed - Bid/Ask 12:54:28 23/05/2024 am IST Pre-market 12:08:31 pm
3.26 EUR +2.84% Intraday chart for OPEN END TURBO LONG - APTARGROUP 3.33 +2.15%
Current month+9.40%
1 month+23.95%
Date Price Change
22/24/22 3.26 +2.84%
21/24/21 3.17 +0.96%
20/24/20 3.14 -2.79%
17/24/17 3.23 +0.62%
16/24/16 3.21 +1.58%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 12:54 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying APTARGROUP, INC.
Issuer Morgan Stanley
WKN MB100F
ISINDE000MB100F1
Date issued 24/11/2022
Strike 113.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.62
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.51
Lowest since issue 0.28
Spread 0.12
Spread %3.54%

Company Profile

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
Sector
-
More about the company

Ratings for AptarGroup, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: AptarGroup, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
148.8 USD
Average target price
159 USD
Spread / Average Target
+6.86%
Consensus